Howard Marks - Oaktree Capital Management
Holding/activity history for Amylyx Pharmaceuticals Inc. (IFIN.U)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2022 Q1 | 0 | 0 | Sell 100.00% | 0.04 | |
| 2021 Q4 | 250,000 | 0.04 | Buy | 0.04 | $10.03 |
Howard Marks - Oaktree Capital Management
Holding/activity history for Amylyx Pharmaceuticals Inc. (IFIN.U)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2022 Q1 | 0 | 0 | Sell 100.00% | 0.04 | |
| 2021 Q4 | 250,000 | 0.04 | Buy | 0.04 | $10.03 |